Comparative genomic hybridization of medulloblastomas and clinical relevance: Eleven new cases and a review of the literature

H. J. Gilhuis, K. L. Anderl, R. H. Boerman, J. M. Jeuken, C. D. James, C. Raffel, B. W. Scheithauer, Robert Brian Jenkins

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Medulloblastomas are highly malignant primitive neuroectodermal tumors of the cerebellum that display a wide variety of histopathological patterns. However, these patterns do not provide an accurate prediction of clinical-biological behavior and no satisfactory morphological grading system has ever been presented. Genetic alterations may provide additional diagnostic information and allow clinically relevant subgrouping of primitive neuroectodermal tumors. We examined 10 medulloblastomas and one medulloblastoma cell line. One amplification site on chromosome 8q24 was detected in the cell line corresponding to the known amplification of the c-myc gene in this cell line. The gain of 2p21-24 in two tumors was shown to represent amplification of the N-myc gene by Southern blot hybridization and fluorescence in situ hybridization. The data show that the isochromosome 17 can be recognized using comparative genomic hybridization (CGH) by the typical combination of loss of 17p combined with gain of 17q. No specific pattern of genetic alterations could be linked to the clinical behavior of the tumors. We have compared our results with previous CGH studies on medulloblastomas.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalClinical Neurology and Neurosurgery
Volume102
Issue number4
DOIs
StatePublished - Dec 1 2000

Fingerprint

Medulloblastoma
Comparative Genomic Hybridization
Primitive Neuroectodermal Tumors
myc Genes
Cell Line
Isochromosomes
Southern Blotting
Fluorescence In Situ Hybridization
Cerebellum
Neoplasms
Chromosomes

Keywords

  • Comparative genomic hybridization
  • Fluorescence in situ hybridization
  • Medulloblastoma
  • Southern blot

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Neurology

Cite this

Comparative genomic hybridization of medulloblastomas and clinical relevance : Eleven new cases and a review of the literature. / Gilhuis, H. J.; Anderl, K. L.; Boerman, R. H.; Jeuken, J. M.; James, C. D.; Raffel, C.; Scheithauer, B. W.; Jenkins, Robert Brian.

In: Clinical Neurology and Neurosurgery, Vol. 102, No. 4, 01.12.2000, p. 203-209.

Research output: Contribution to journalArticle

Gilhuis, H. J. ; Anderl, K. L. ; Boerman, R. H. ; Jeuken, J. M. ; James, C. D. ; Raffel, C. ; Scheithauer, B. W. ; Jenkins, Robert Brian. / Comparative genomic hybridization of medulloblastomas and clinical relevance : Eleven new cases and a review of the literature. In: Clinical Neurology and Neurosurgery. 2000 ; Vol. 102, No. 4. pp. 203-209.
@article{6b4e94b87e2b446eaa58cdc1a9be27ab,
title = "Comparative genomic hybridization of medulloblastomas and clinical relevance: Eleven new cases and a review of the literature",
abstract = "Medulloblastomas are highly malignant primitive neuroectodermal tumors of the cerebellum that display a wide variety of histopathological patterns. However, these patterns do not provide an accurate prediction of clinical-biological behavior and no satisfactory morphological grading system has ever been presented. Genetic alterations may provide additional diagnostic information and allow clinically relevant subgrouping of primitive neuroectodermal tumors. We examined 10 medulloblastomas and one medulloblastoma cell line. One amplification site on chromosome 8q24 was detected in the cell line corresponding to the known amplification of the c-myc gene in this cell line. The gain of 2p21-24 in two tumors was shown to represent amplification of the N-myc gene by Southern blot hybridization and fluorescence in situ hybridization. The data show that the isochromosome 17 can be recognized using comparative genomic hybridization (CGH) by the typical combination of loss of 17p combined with gain of 17q. No specific pattern of genetic alterations could be linked to the clinical behavior of the tumors. We have compared our results with previous CGH studies on medulloblastomas.",
keywords = "Comparative genomic hybridization, Fluorescence in situ hybridization, Medulloblastoma, Southern blot",
author = "Gilhuis, {H. J.} and Anderl, {K. L.} and Boerman, {R. H.} and Jeuken, {J. M.} and James, {C. D.} and C. Raffel and Scheithauer, {B. W.} and Jenkins, {Robert Brian}",
year = "2000",
month = "12",
day = "1",
doi = "10.1016/S0303-8467(00)00112-8",
language = "English (US)",
volume = "102",
pages = "203--209",
journal = "Clinical Neurology and Neurosurgery",
issn = "0303-8467",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Comparative genomic hybridization of medulloblastomas and clinical relevance

T2 - Eleven new cases and a review of the literature

AU - Gilhuis, H. J.

AU - Anderl, K. L.

AU - Boerman, R. H.

AU - Jeuken, J. M.

AU - James, C. D.

AU - Raffel, C.

AU - Scheithauer, B. W.

AU - Jenkins, Robert Brian

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Medulloblastomas are highly malignant primitive neuroectodermal tumors of the cerebellum that display a wide variety of histopathological patterns. However, these patterns do not provide an accurate prediction of clinical-biological behavior and no satisfactory morphological grading system has ever been presented. Genetic alterations may provide additional diagnostic information and allow clinically relevant subgrouping of primitive neuroectodermal tumors. We examined 10 medulloblastomas and one medulloblastoma cell line. One amplification site on chromosome 8q24 was detected in the cell line corresponding to the known amplification of the c-myc gene in this cell line. The gain of 2p21-24 in two tumors was shown to represent amplification of the N-myc gene by Southern blot hybridization and fluorescence in situ hybridization. The data show that the isochromosome 17 can be recognized using comparative genomic hybridization (CGH) by the typical combination of loss of 17p combined with gain of 17q. No specific pattern of genetic alterations could be linked to the clinical behavior of the tumors. We have compared our results with previous CGH studies on medulloblastomas.

AB - Medulloblastomas are highly malignant primitive neuroectodermal tumors of the cerebellum that display a wide variety of histopathological patterns. However, these patterns do not provide an accurate prediction of clinical-biological behavior and no satisfactory morphological grading system has ever been presented. Genetic alterations may provide additional diagnostic information and allow clinically relevant subgrouping of primitive neuroectodermal tumors. We examined 10 medulloblastomas and one medulloblastoma cell line. One amplification site on chromosome 8q24 was detected in the cell line corresponding to the known amplification of the c-myc gene in this cell line. The gain of 2p21-24 in two tumors was shown to represent amplification of the N-myc gene by Southern blot hybridization and fluorescence in situ hybridization. The data show that the isochromosome 17 can be recognized using comparative genomic hybridization (CGH) by the typical combination of loss of 17p combined with gain of 17q. No specific pattern of genetic alterations could be linked to the clinical behavior of the tumors. We have compared our results with previous CGH studies on medulloblastomas.

KW - Comparative genomic hybridization

KW - Fluorescence in situ hybridization

KW - Medulloblastoma

KW - Southern blot

UR - http://www.scopus.com/inward/record.url?scp=0034541832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034541832&partnerID=8YFLogxK

U2 - 10.1016/S0303-8467(00)00112-8

DO - 10.1016/S0303-8467(00)00112-8

M3 - Article

C2 - 11154805

AN - SCOPUS:0034541832

VL - 102

SP - 203

EP - 209

JO - Clinical Neurology and Neurosurgery

JF - Clinical Neurology and Neurosurgery

SN - 0303-8467

IS - 4

ER -